tradingkey.logo

Ironwood Pharmaceuticals Provides Clinical And Regulatory Update On Apraglutide

ReutersApr 14, 2025 11:07 AM

- Ironwood Pharmaceuticals Inc IRWD.O:

  • IRONWOOD PHARMACEUTICALS PROVIDES CLINICAL AND REGULATORY UPDATE ON APRAGLUTIDE

  • IRONWOOD PHARMACEUTICALS INC - ENGAGES GOLDMAN SACHS TO EXPLORE STRATEGIC ALTERNATIVES

  • IRONWOOD PHARMACEUTICALS INC - REQUIRES CONFIRMATORY PHASE 3 TRIAL FOR APRAGLUTIDE APPROVAL

  • IRONWOOD PHARMACEUTICALS INC - TO WORK WITH FDA ON CONFIRMATORY PHASE 3 TRIAL DESIGN

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI